Risk of Cardiovascular Disease Is Associated with Cognitive Decline Later in Life
Individuals with a higher risk of cardiovascular disease (CVD) demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease, according to the results of a recent study.
Individuals with a higher risk of cardiovascular disease (CVD) demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease, according to the results of a recent study.
Furthermore, monitoring and controlling for CVD may be critical to maintaining and improving cognitive health later in life.1 The study results showed that a higher CVD risk burden was associated with an increased rate of decline in episodic memory, perceptual speed, and working memory.1
“In the absence of effective treatments for dementia, we need to monitor and control cardiovascular risk burden as a way to maintain patients’ cognitive health as they age,” Weili Xu, PhD, Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China, said in a statement. “Given the progressive increase in the number of dementia cases worldwide, our findings have both clinical and public health relevance.”2
REFERENCES
- Song R, Xu H, Dintica CS, et al. Associations between cardiovascular risk, structural brain changes, and cognitive decline. J Am Coll Cardiol. 2020;75(20):2525-2534. doi:10.1016/j.jacc.2020.03.053
- Maintaining heart health may protect against cognitive decline. ScienceDaily. May 18, 2020. Accessed July 23, 2020. sciencedaily.com/releases/2020/05/200518144842.htm
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025